about
Human embryonic and neuronal stem cell markers in retinoblastomaStem cell markers: ABCG2 and MCM2 expression in retinoblastomaMinimal residual disease in breast cancer: an overview of circulating and disseminated tumour cellsCirculating cancer stem cells: the importance to selectEmerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approachLoukoumasomes Are Distinct Subcellular Structures from Rods and Rings and Are Structurally Associated with MAP2 and the Nuclear Envelope in Retinal CellsAdvances in complex multiparameter flow cytometry technology: Applications in stem cell research.Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsivenessPersistence of side population cells with high drug efflux capacity in pancreatic cancer.Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas.Lithium chloride regulates the proliferation of stem-like cells in retinoblastoma cell lines: a potential role for the canonical Wnt signaling pathway.Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant.Differential expression of stem cell markers and vascular endothelial growth factor in human retinoblastoma tissue.p75 neurotrophin receptor: A potential surface marker of tongue squamous cell carcinoma stem cells.Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapiesHigh aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cellsVascular Recruitment of Human Retinoblastoma Cells by Multi-Cellular Adhesive Interactions with Circulating Leukocytes.Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer.Characterization and retinal neuron differentiation of WERI-Rb1 cancer stem cells.Enhanced SOX2 expression in retinoblastoma tissues and peripheral blood is associated with the clinicopathological characteristics of the diseaseAcute lymphoid leukemia cells with greater stem cell antigen-1 (Ly6a/Sca-1) expression exhibit higher levels of metalloproteinase activity and are more aggressive in vivo.Regulation of mitotic cytoskeleton dynamics and cytokinesis by integrin-linked kinase in retinoblastoma cells.The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties.Inconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastomaRecent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway.Immunoreactivity of Pluripotent Markers SSEA-5 and L1CAM in Human Tumors, Teratomas, and Induced Pluripotent Stem CellsRetinoblastoma: Recent trends A mini review based on published literature.EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell-mediated immunotherapyTherapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy.Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters.A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potentialResidual intraretinal retinoblastoma after chemoreduction failureSide population cells isolated from KATO III human gastric cancer cell line have cancer stem cell-like characteristicsRB116: an RB1+ retinoblastoma cell line expressing primitive markers.Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus.Role of B lymphoma Mo-MLV insertion region 1 in the oncogenic behavior of retinoblastomas.The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype.HER2/ERBB2 immunoreactivity in human retinoblastoma.Deoxycholate promotes survival of breast cancer cells by reducing the level of pro-apoptotic ceramide.
P2860
Q24647640-88B3275B-D8D3-47DE-815F-B768F6E30C43Q24679483-B1F250CE-ACDD-4090-90E8-29FB5A5F4524Q26748850-B9531EF2-C16B-4B43-AE3B-079BFE46A710Q26778924-5B4C634A-3D52-4240-B2B3-CA13CC1C5EE3Q26849477-B67D87CA-B40C-42F2-90A7-5364E4888A1EQ28553081-DB1D03D2-29CE-43BA-9603-248CCE922397Q30479710-AF962E71-C598-40F8-9357-78697393E8E6Q33250633-CA6E19E3-5B3A-4E46-8085-2798EEE479BDQ33317784-0227BD5A-9BDE-4C58-A71F-2B45B736339EQ33398823-F1F87EA3-ADC4-474E-89C6-BB620E196058Q33523529-40995C40-6A78-42BF-A69E-239D8250AC85Q33547790-45FA8A7B-137B-419D-80E1-5278C8E939CFQ33635145-4A3EEF81-F140-4987-8878-843897E2DA58Q33671652-36CFE82E-A956-41AA-AE3F-AAAD701DD66FQ33730375-A9E8F64E-BDDA-4402-B828-6967AD8F468BQ33919540-A708785F-18DE-4F01-9E36-75B51E31CE85Q34015100-002070EB-D8C6-4826-9203-62CF6D6A7825Q34137275-60DF805D-B8AE-47C6-905C-388EFDA50AB0Q34437435-7563A3C7-C9BA-46BB-926C-F6316C1A4F16Q35042144-467B1721-EDDA-43A9-888F-25C740744911Q35106493-8A45E401-B29E-467C-93D1-FCD248259936Q35184072-B7C7B6D5-FAEF-479B-BEB7-D1514F1F64A6Q35247713-9FA1F6E9-189A-40BB-98D8-C9A279E6019EQ35440815-AC317FC0-80DC-4F76-A38D-36B4918EE303Q35459525-E6D54C03-FE33-4531-A1EC-4C9D60DBED93Q35560334-CB268A15-8769-4005-8B6F-D01366D9185FQ35623479-68F53A7B-7725-4258-84E2-CCD40468E288Q35686255-DA2469ED-D737-4AFF-A6CB-038EC273520CQ35745241-17547138-32C2-4025-A1C7-43232DB22FCEQ35876285-4E60A3D8-B274-45DB-B752-74EE7FCD29B3Q35919726-68892FBC-A9AC-4EB5-982F-EBAA2E73A04FQ36028412-29DEA856-268D-40B9-9E6D-37EFFC33DA2FQ36157681-E644CCCE-1E8B-4107-B700-4150FD91AB16Q36214625-16BFB658-189D-44C3-9913-944370091AAEQ36458932-D0CD3FD7-6287-4FA6-9BAC-4DFB43ED2782Q36663418-98F892A7-6624-49C9-8890-8029805716D8Q36727745-09A5E0AC-AB98-4792-976F-A4BA8C656E19Q36778291-48EBDB6F-806C-47FD-954D-159F740E4620Q36923901-7290F9C5-DA46-4BBC-8B5C-B6551600B777Q37131369-0DF4BF8C-9F60-45DF-A529-D07ED478245A
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cancer stem cell characteristics in retinoblastoma.
@ast
Cancer stem cell characteristics in retinoblastoma.
@en
type
label
Cancer stem cell characteristics in retinoblastoma.
@ast
Cancer stem cell characteristics in retinoblastoma.
@en
prefLabel
Cancer stem cell characteristics in retinoblastoma.
@ast
Cancer stem cell characteristics in retinoblastoma.
@en
P2093
P1433
P1476
Cancer stem cell characteristics in retinoblastoma
@en
P2093
Federico Gonzalez-Fernandez
Gail M Seigel
Lorrie M Campbell
Malathi Narayan
P304
P577
2005-09-12T00:00:00Z